Loading organizations...
Loading organizations...
Biopharmaceutical company developing therapies for heart failure.
Cardiorentis has raised $117.8M across 2 funding rounds.
Cardiorentis has raised $117.8M in total across 2 funding rounds.
Cardiorentis has raised $117.8M in total across 2 funding rounds.
Cardiorentis's investors include HealthCare Royalty Partners.
Cardiorentis has raised $117.8M across 2 funding rounds. Most recently, it raised $60.0M Series B in January 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 11, 2016 | $60.0M Series B | ||
| Sep 19, 2014 | $57.8M Other Equity | HealthCare Royalty Partners |